# FDA Inspection 1219100 - Aveo Pharmaceuticals Inc. - September 15, 2023

Source: https://www.keypedia.com/records/fda_inspections/aveo-pharmaceuticals-inc/13dd7ca8-0ba2-48e3-93d0-03cd0aad6482
Source feed: FDA_Inspections

> FDA Inspection 1219100 for Aveo Pharmaceuticals Inc. on September 15, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1219100
- Company Name: Aveo Pharmaceuticals Inc.
- Inspection Date: 2023-09-15
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1131272 - 2020-09-30](https://www.keypedia.com/records/fda_inspections/aveo-pharmaceuticals-inc/a677ceac-e93a-41c7-a524-5c82d5132f20)
- [FDA Inspection 813741 - 2013-01-08](https://www.keypedia.com/records/fda_inspections/aveo-pharmaceuticals-inc/e5dcc826-342b-413f-ba1a-a8041c9a339e)

Company: https://www.keypedia.com/companies/aveo-pharmaceuticals-inc/a2eaa018-1540-42fe-9d11-7e0e3b465daa

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c